Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 309

1.

Text Messaging for Disease Monitoring in Childhood Nephrotic Syndrome.

Wang CS, Troost JP, Greenbaum LA, Srivastava T, Reidy K, Gibson K, Trachtman H, Piette JD, Sethna CB, Meyers K, Dell KM, Tran CL, Vento S, Kallem K, Herreshoff E, Hingorani S, Lemley K, Oh G, Brown E, Lin JJ, Kaskel F, Gipson DS.

Kidney Int Rep. 2019 May 7;4(8):1066-1074. doi: 10.1016/j.ekir.2019.04.026. eCollection 2019 Aug.

2.

Knowledge and use of recruitment support tools among study coordinators at an academic medical center: The Novel Approaches to Recruitment Planning Study.

Scott E, McComb B, Trachtman H, Mannon L, Rosenfeld P, Thornton R, Bougrab N, Sherman S, Langford A.

Contemp Clin Trials Commun. 2019 Jul 22;15:100424. doi: 10.1016/j.conctc.2019.100424. eCollection 2019 Sep.

3.

Plasma Zonulin Levels in Childhood Nephrotic Syndrome.

Trachtman H, Gipson DS, Lemley KV, Troost JP, Faul C, Morrison DJ, Vento SM, Ahn DH, Goldberg JD.

Front Pediatr. 2019 May 16;7:197. doi: 10.3389/fped.2019.00197. eCollection 2019.

4.

Tonsillectomy for the Management of Immunoglobulin A Nephropathy.

Trachtman H.

JAMA Netw Open. 2019 May 3;2(5):e194755. doi: 10.1001/jamanetworkopen.2019.4755. No abstract available.

PMID:
31150070
5.

Using PROMIS® to create clinically meaningful profiles of nephrotic syndrome patients.

Troost JP, Gipson DS, Carlozzi NE, Reeve BB, Nachman PH, Gbadegesin R, Wang J, Modersitzki F, Massengill S, Mahan JD, Liu Y, Trachtman H, Herreshoff EG, DeWalt DA, Selewski DT.

Health Psychol. 2019 May;38(5):410-421. doi: 10.1037/hea0000679.

6.

Research imperative.

Trachtman H.

Contemp Clin Trials Commun. 2019 Mar 24;14:100350. doi: 10.1016/j.conctc.2019.100350. eCollection 2019 Jun.

7.

Data monitoring committees and randomized clinical trials.

Trachtman H, Caplan AL.

Kidney Int. 2019 Apr;95(4):992. doi: 10.1016/j.kint.2018.12.012. No abstract available.

PMID:
30904070
8.

Prevalence of low molecular weight proteinuria and Dent disease 1 CLCN5 mutations in proteinuric cohorts.

Beara-Lasic L, Cogal A, Mara K, Enders F, Mehta RA, Haskic Z, Furth SL, Trachtman H, Scheinman SJ, Milliner DS, Goldfarb DS, Harris PC, Lieske JC; investigators of the Rare Kidney Stone Consortium.

Pediatr Nephrol. 2019 Mar 10. doi: 10.1007/s00467-019-04210-0. [Epub ahead of print]

PMID:
30852663
9.

Hypokalemia Associated With a Claudin 10 Mutation: A Case Report.

Meyers N, Nelson-Williams C, Malaga-Dieguez L, Kaufmann H, Loring E, Knight J, Lifton RP, Trachtman H.

Am J Kidney Dis. 2019 Mar;73(3):425-428. doi: 10.1053/j.ajkd.2018.08.015. Epub 2018 Oct 25.

PMID:
30482581
10.

Does What Goes Around Always Come Around?

Trachtman H.

Clin J Am Soc Nephrol. 2018 Dec 7;13(12):1788-1790. doi: 10.2215/CJN.12291018. Epub 2018 Nov 15. No abstract available.

PMID:
30442862
11.

CureGN Study Rationale, Design, and Methods: Establishing a Large Prospective Observational Study of Glomerular Disease.

Mariani LH, Bomback AS, Canetta PA, Flessner MF, Helmuth M, Hladunewich MA, Hogan JJ, Kiryluk K, Nachman PH, Nast CC, Rheault MN, Rizk DV, Trachtman H, Wenderfer SE, Bowers C, Hill-Callahan P, Marasa M, Poulton CJ, Revell A, Vento S, Barisoni L, Cattran D, D'Agati V, Jennette JC, Klein JB, Laurin LP, Twombley K, Falk RJ, Gharavi AG, Gillespie BW, Gipson DS, Greenbaum LA, Holzman LB, Kretzler M, Robinson B, Smoyer WE, Guay-Woodford LM; CureGN Consortium.

Am J Kidney Dis. 2019 Feb;73(2):218-229. doi: 10.1053/j.ajkd.2018.07.020. Epub 2018 Nov 9.

PMID:
30420158
12.

DUET: A Phase 2 Study Evaluating the Efficacy and Safety of Sparsentan in Patients with FSGS.

Trachtman H, Nelson P, Adler S, Campbell KN, Chaudhuri A, Derebail VK, Gambaro G, Gesualdo L, Gipson DS, Hogan J, Lieberman K, Marder B, Meyers KE, Mustafa E, Radhakrishnan J, Srivastava T, Stepanians M, Tesar V, Zhdanova O, Komers R; DUET Study Group.

J Am Soc Nephrol. 2018 Nov;29(11):2745-2754. doi: 10.1681/ASN.2018010091.

PMID:
30361325
13.

Renal Function and exposure to Bisphenol A and phthalates in children with Chronic Kidney Disease.

Malits J, Attina TM, Karthikraj R, Kannan K, Naidu M, Furth S, Warady BA, Vento S, Trachtman H, Trasande L.

Environ Res. 2018 Nov;167:575-582. doi: 10.1016/j.envres.2018.08.006. Epub 2018 Aug 9.

PMID:
30172191
14.

Interstitial nephritis: Two pediatric cases with atypical radiological features.

Connors J, Aronov R, Malaga-Dieguez L, Vento S, Pehrson LJ, Wu M, Lala S, Trachtman H.

Radiol Case Rep. 2018 Aug 12;13(5):1003-1006. doi: 10.1016/j.radcr.2018.07.011. eCollection 2018 Oct.

15.

Data monitoring committees and stopping trials-Giving participants a voice.

Trachtman H, Caplan A.

Contemp Clin Trials. 2018 May;68:146. doi: 10.1016/j.cct.2018.03.009. Epub 2018 Mar 19. No abstract available.

PMID:
29567282
16.

Randomized Clinical Trial Design to Assess Abatacept in Resistant Nephrotic Syndrome.

Trachtman H, Gipson DS, Somers M, Spino C, Adler S, Holzman L, Kopp JB, Sedor J, Overfield S, Elegbe A, Maldonado M, Greka A.

Kidney Int Rep. 2017 Aug 31;3(1):115-121. doi: 10.1016/j.ekir.2017.08.013. eCollection 2018 Jan.

17.

An Outcomes-Based Definition of Proteinuria Remission in Focal Segmental Glomerulosclerosis.

Troost JP, Trachtman H, Nachman PH, Kretzler M, Spino C, Komers R, Tuller S, Perumal K, Massengill SF, Kamil ES, Oh G, Selewski DT, Gipson P, Gipson DS.

Clin J Am Soc Nephrol. 2018 Mar 7;13(3):414-421. doi: 10.2215/CJN.04780517. Epub 2017 Nov 22.

18.

Efficacy and Safety of Sparsentan Compared With Irbesartan in Patients With Primary Focal Segmental Glomerulosclerosis: Randomized, Controlled Trial Design (DUET).

Komers R, Gipson DS, Nelson P, Adler S, Srivastava T, Derebail VK, Meyers KE, Pergola P, MacNally ME, Hunt JL, Shih A, Trachtman H.

Kidney Int Rep. 2017 Mar 4;2(4):654-664. doi: 10.1016/j.ekir.2017.02.019. eCollection 2017 Jul.

19.

Association of Serum Soluble Urokinase Receptor Levels With Progression of Kidney Disease in Children.

Schaefer F, Trachtman H, Wühl E, Kirchner M, Hayek SS, Anarat A, Duzova A, Mir S, Paripovic D, Yilmaz A, Lugani F, Arbeiter K, Litwin M, Oh J, Matteucci MC, Gellermann J, Wygoda S, Jankauskiene A, Klaus G, Dusek J, Testa S, Zurowska A, Caldas Afonso A, Tracy M, Wei C, Sever S, Smoyer W, Reiser J; ESCAPE Trial Consortium and the 4C Study Group.

JAMA Pediatr. 2017 Nov 6;171(11):e172914. doi: 10.1001/jamapediatrics.2017.2914. Epub 2017 Nov 6. Erratum in: JAMA Pediatr. 2017 Nov 1;171(11):1127.

20.

Responsiveness of the PROMIS® measures to changes in disease status among pediatric nephrotic syndrome patients: a Midwest pediatric nephrology consortium study.

Selewski DT, Troost JP, Cummings D, Massengill SF, Gbadegesin RA, Greenbaum LA, Shatat IF, Cai Y, Kapur G, Hebert D, Somers MJ, Trachtman H, Pais P, Seifert ME, Goebel J, Sethna CB, Mahan JD, Gross HE, Herreshoff E, Liu Y, Carlozzi NE, Reeve BB, DeWalt DA, Gipson DS.

Health Qual Life Outcomes. 2017 Aug 23;15(1):166. doi: 10.1186/s12955-017-0737-2.

21.

Investigational drugs in development for focal segmental glomerulosclerosis.

Trachtman H.

Expert Opin Investig Drugs. 2017 Aug;26(8):945-952. doi: 10.1080/13543784.2017.1351544. Epub 2017 Jul 14. Review.

PMID:
28707483
22.

Medical Companionship.

Trachtman H.

Camb Q Healthc Ethics. 2017 Jul;26(3):518-520. doi: 10.1017/S0963180116001201. No abstract available.

PMID:
28541175
23.

Early manifestations of renal disease in patients with tuberous sclerosis complex.

Malaga-Dieguez L, Spencer R, Pehrson LJ, Vento S, Menzer K, Devinsky O, Trachtman H.

Int J Nephrol Renovasc Dis. 2017 May 2;10:91-95. doi: 10.2147/IJNRD.S123638. eCollection 2017.

24.

Learning to live with nephrotic syndrome: experiences of adult patients and parents of children with nephrotic syndrome.

Beanlands H, Maione M, Poulton C, Herreshoff E, Hladunewich MA, Hailperin M, Modes MM, An L, Nunes JW, Trachtman H, Nachman P, Gipson DS.

Nephrol Dial Transplant. 2017 Jan 1;32(suppl_1):i98-i105. doi: 10.1093/ndt/gfw344.

25.

Provider perspectives on treatment decision-making in nephrotic syndrome.

Hladunewich MA, Beanlands H, Herreshoff E, Troost JP, Maione M, Trachtman H, Poulton C, Nachman P, Modes MM, Hailperin M, Pitter R, Gipson DS.

Nephrol Dial Transplant. 2017 Jan 1;32(suppl_1):i106-i114. doi: 10.1093/ndt/gfw309.

26.

Interstitial fibrosis scored on whole-slide digital imaging of kidney biopsies is a predictor of outcome in proteinuric glomerulopathies.

Mariani LH, Martini S, Barisoni L, Canetta PA, Troost JP, Hodgin JB, Palmer M, Rosenberg AZ, Lemley KV, Chien HP, Zee J, Smith A, Appel GB, Trachtman H, Hewitt SM, Kretzler M, Bagnasco SM.

Nephrol Dial Transplant. 2018 Feb 1;33(2):310-318. doi: 10.1093/ndt/gfw443.

27.

Exposure to bisphenols and phthalates and association with oxidant stress, insulin resistance, and endothelial dysfunction in children.

Kataria A, Levine D, Wertenteil S, Vento S, Xue J, Rajendiran K, Kannan K, Thurman JM, Morrison D, Brody R, Urbina E, Attina T, Trasande L, Trachtman H.

Pediatr Res. 2017 Jun;81(6):857-864. doi: 10.1038/pr.2017.16. Epub 2017 Jan 18.

28.

The Effect of a Gluten-Free Diet in Children With Difficult-to-Manage Nephrotic Syndrome.

Lemley KV, Faul C, Schramm K, Meyers K, Kaskel F, Dell KM, Gipson DS, Gibson K, Trachtman H.

Pediatrics. 2016 Jul;138(1). pii: e20154528. doi: 10.1542/peds.2015-4528.

29.

Patient-Reported Outcomes in Glomerular Disease.

Selewski DT, Thompson A, Kovacs S, Papadopoulos EJ, Carlozzi NE, Trachtman H, Troost JP, Merkel PA, Gipson DS.

Clin J Am Soc Nephrol. 2017 Jan 6;12(1):140-148. doi: 10.2215/CJN.13231215. Epub 2016 Jun 3. Review.

30.

Traveling in Other People׳s Shoes.

Trachtman H.

Curr Probl Pediatr Adolesc Health Care. 2016 May;46(5):158-9. doi: 10.1016/j.cppeds.2016.02.002. Epub 2016 Mar 17. No abstract available.

PMID:
26996729
31.

Recurrent focal segmental glomerulosclerosis after kidney transplantation: response to comments by Straatmann and Vehaskari.

Trachtman H, Trachtman R.

Pediatr Nephrol. 2016 Aug;31(8):1377. doi: 10.1007/s00467-015-3250-z. Epub 2016 Mar 3. No abstract available.

PMID:
26939681
32.

Melamine Nephrotoxicity is Mediated by Hyperuricemia.

Zhang L, Li HT, Wang LL, Trachtman H, Trasande L, Wang PX, Liu JM.

Biomed Environ Sci. 2015 Dec;28(12):904-12. doi: 10.3967/bes2015.124.

33.

Complete Remission in the Nephrotic Syndrome Study Network.

Gipson DS, Troost JP, Lafayette RA, Hladunewich MA, Trachtman H, Gadegbeku CA, Sedor JR, Holzman LB, Moxey-Mims MM, Perumal K, Kaskel FJ, Nelson PJ, Tuttle KR, Bagnasco SM, Hogan MC, Dell KM, Appel GB, Lieske JC, Ilori TO, Sethna CB, Fervenza FC, Hogan SL, Nachman PH, Rosenberg AZ, Greenbaum LA, Meyers KE, Hewitt SM, Choi MJ, Kopp JB, Zhdanova O, Hodgin JB, Johnstone DB, Adler SG, Avila-Casado C, Neu AM, Hingorani SR, Lemley KV, Nast CC, Brady TM, Barisoni-Thomas L, Fornoni A, Jennette JC, Cattran DC, Palmer MB, Gibson KL, Reich HN, Mokrzycki MH, Sambandam KK, Zilleruelo GE, Licht C, Sampson MG, Song P, Mariani LH, Kretzler M.

Clin J Am Soc Nephrol. 2016 Jan 7;11(1):81-9. doi: 10.2215/CJN.02560315. Epub 2015 Dec 10.

34.

Busy Bs.

Trachtman H.

J Am Soc Nephrol. 2016 Jun;27(6):1584-6. doi: 10.1681/ASN.2015101171. Epub 2015 Nov 30. No abstract available.

35.

Urinary polycyclic aromatic hydrocarbons and measures of oxidative stress, inflammation and renal function in adolescents: NHANES 2003-2008.

Farzan SF, Chen Y, Trachtman H, Trasande L.

Environ Res. 2016 Jan;144(Pt A):149-157. doi: 10.1016/j.envres.2015.11.012. Epub 2015 Nov 21.

36.

Association between perfluoroalkyl acids and kidney function in a cross-sectional study of adolescents.

Kataria A, Trachtman H, Malaga-Dieguez L, Trasande L.

Environ Health. 2015 Nov 21;14:89. doi: 10.1186/s12940-015-0077-9.

37.

Soluble Urokinase Receptor and Chronic Kidney Disease.

Hayek SS, Sever S, Ko YA, Trachtman H, Awad M, Wadhwani S, Altintas MM, Wei C, Hotton AL, French AL, Sperling LS, Lerakis S, Quyyumi AA, Reiser J.

N Engl J Med. 2015 Nov 12;373(20):1916-25. doi: 10.1056/NEJMoa1506362. Epub 2015 Nov 5.

38.

A possible influence of age on absorption and elimination of adalimumab in focal segmental glomerulosclerosis (FSGS).

Ternant D, Paintaud G, Trachtman H, Gipson DS, Joy MS.

Eur J Clin Pharmacol. 2016 Feb;72(2):253-5. doi: 10.1007/s00228-015-1973-1. Epub 2015 Oct 31. No abstract available.

PMID:
26521258
39.

Complement Activation in Patients with Focal Segmental Glomerulosclerosis.

Thurman JM, Wong M, Renner B, Frazer-Abel A, Giclas PC, Joy MS, Jalal D, Radeva MK, Gassman J, Gipson DS, Kaskel F, Friedman A, Trachtman H.

PLoS One. 2015 Sep 3;10(9):e0136558. doi: 10.1371/journal.pone.0136558. eCollection 2015.

40.

Efficacy of galactose and adalimumab in patients with resistant focal segmental glomerulosclerosis: report of the font clinical trial group.

Trachtman H, Vento S, Herreshoff E, Radeva M, Gassman J, Stein DT, Savin VJ, Sharma M, Reiser J, Wei C, Somers M, Srivastava T, Gipson DS.

BMC Nephrol. 2015 Jul 22;16:111. doi: 10.1186/s12882-015-0094-5.

41.

Adiponectin in children and young adults with focal segmental glomerulosclerosis.

Sethna CB, Boone V, Kwok J, Jun D, Trachtman H.

Pediatr Nephrol. 2015 Nov;30(11):1977-85. doi: 10.1007/s00467-015-3146-y. Epub 2015 Jun 27.

PMID:
26115618
42.

The effects of environmental chemicals on renal function.

Kataria A, Trasande L, Trachtman H.

Nat Rev Nephrol. 2015 Oct;11(10):610-25. doi: 10.1038/nrneph.2015.94. Epub 2015 Jun 23. Review.

43.

Recurrent gain of function mutation in calcium channel CACNA1H causes early-onset hypertension with primary aldosteronism.

Scholl UI, Stölting G, Nelson-Williams C, Vichot AA, Choi M, Loring E, Prasad ML, Goh G, Carling T, Juhlin CC, Quack I, Rump LC, Thiel A, Lande M, Frazier BG, Rasoulpour M, Bowlin DL, Sethna CB, Trachtman H, Fahlke C, Lifton RP.

Elife. 2015 Apr 24;4:e06315. doi: 10.7554/eLife.06315.

44.

Direct Reversible Kidney Injury in Familial Hemophagocytic Lymphohistiocytosis Type 3.

Malaga-Dieguez L, Ming W, Trachtman H.

J Am Soc Nephrol. 2015 Aug;26(8):1777-80. doi: 10.1681/ASN.2014111090. Epub 2015 Apr 9.

45.

Pharmacokinetics, Pharmacodynamics, and Safety of Lisinopril in Pediatric Kidney Transplant Patients: Implications for Starting Dose Selection.

Trachtman H, Frymoyer A, Lewandowski A, Greenbaum LA, Feig DI, Gipson DS, Warady BA, Goebel JW, Schwartz GJ, Lewis K, Anand R, Patel UD; Best Pharmaceuticals for Children Act-Pediatric Trials Network Administrative Core Committee.

Clin Pharmacol Ther. 2015 Jul;98(1):25-33. doi: 10.1002/cpt.127. Epub 2015 May 2.

46.

The impact of disease duration on quality of life in children with nephrotic syndrome: a Midwest Pediatric Nephrology Consortium study.

Selewski DT, Troost JP, Massengill SF, Gbadegesin RA, Greenbaum LA, Shatat IF, Cai Y, Kapur G, Hebert D, Somers MJ, Trachtman H, Pais P, Seifert ME, Goebel J, Sethna CB, Mahan JD, Gross HE, Herreshoff E, Liu Y, Song PX, Reeve BB, DeWalt DA, Gipson DS.

Pediatr Nephrol. 2015 Sep;30(9):1467-76. doi: 10.1007/s00467-015-3074-x. Epub 2015 Mar 18.

47.

Novel therapies for FSGS: preclinical and clinical studies.

Malaga-Dieguez L, Bouhassira D, Gipson D, Trachtman H.

Adv Chronic Kidney Dis. 2015 Mar;22(2):e1-6. doi: 10.1053/j.ackd.2014.10.001. Review.

PMID:
25704355
48.

Recurrent focal segmental glomerulosclerosis after kidney transplantation.

Trachtman R, Sran SS, Trachtman H.

Pediatr Nephrol. 2015 Oct;30(10):1793-802. doi: 10.1007/s00467-015-3062-1. Epub 2015 Feb 19.

PMID:
25690943
49.

Hemolytic uremic syndrome: toxins, vessels, and inflammation.

Cheung V, Trachtman H.

Front Med (Lausanne). 2014 Nov 4;1:42. doi: 10.3389/fmed.2014.00042. eCollection 2014. Review.

50.

The grand challenge of nephrology.

Trachtman H, Benzing T, Sever S, Harris RC, Reiser J.

Front Med (Lausanne). 2014 Sep 18;1:28. doi: 10.3389/fmed.2014.00028. eCollection 2014. No abstract available.

Supplemental Content

Loading ...
Support Center